A

Amicus Therapeutics

560 employees

Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Pharmaceutical

Date founded

2002

Funding rounds raised

Total raised

$400M

from 8 investors over 8 rounds

A

Amicus Therapeutics raised $400M on October 2, 2023

Investors: GSO Capital Partners

A

Amicus Therapeutics raised $400M on July 17, 2020

Investors: Hayfin Capital Management LLP

A

Amicus Therapeutics raised $10M on December 31, 2013

Investors: Oxford Finance LLC and MidCap Financial

A

Amicus Therapeutics raised $60M on September 14, 2006

Investors: Frazier Healthcare Partners, Prospect Venture Partners, LP, Canaan and Radius Ventures

FAQ